GENERAL ELECTRIC CO
For the period ended Jun 30, 2025. Filed Jul 21, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statement of Changes in Shareholders' Equity
| STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) | Three months ended June 30 | Six months ended June 30 | ||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Common stock issued | $15 | $15 | $15 | $15 |
| Beginning balance | (3,733) | (5,603) | (3,861) | (6,150) |
| Currency translation adjustments | (12) | 2,144 | (19) | 2,109 |
| Benefit plans | (193) | (780) | (327) | (980) |
| Investment securities and cash flow hedges | 110 | (314) | 428 | (768) |
| Long-duration insurance contracts | (196) | 518 | (244) | 1,753 |
| Accumulated other comprehensive income (loss) | $(4,024) | $(4,035) | $(4,024) | $(4,035) |
| Beginning balance | 23,912 | 25,887 | 24,266 | 26,962 |
| Gains (losses) on treasury stock dispositions | (181) | (686) | (626) | (1,877) |
| Stock-based compensation | 101 | 118 | 192 | 232 |
| Other changes | 6 | (36) | 6 | (35) |
| Other capital | $23,839 | $25,282 | $23,839 | $25,282 |
| Beginning balance | 82,081 | 88,090 | 80,488 | 86,553 |
| Net income (loss) attributable to the Company | 2,028 | 1,266 | 4,006 | 2,805 |
| Dividends and other transactions with shareholders(a) | (383) | (11,989) | (769) | (11,987) |
| Other | — | (18) | — | (21) |
| Retained earnings | $83,726 | $77,349 | $83,726 | $77,349 |
| Beginning balance | (83,024) | (78,508) | (81,566) | (79,976) |
| Purchases | (1,745) | (2,335) | (3,717) | (2,652) |
| Dispositions | 347 | 831 | 862 | 2,615 |
| Common stock held in treasury | $(84,421) | $(80,013) | $(84,421) | $(80,013) |
| GE Aerospace shareholders' equity balance | 19,135 | 18,598 | 19,135 | 18,598 |
| Noncontrolling interests balance | 210 | 245 | 210 | 245 |
| Total equity balance at June 30 | $19,345 | $18,843 | $19,345 | $18,843 |
| (a) Included an $11,375 million decrease in Retained earnings reflecting a distribution of all the shares of GE Vernova on April 2, 2024. | ||||
182025 2Q FORM 10-Q
NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, contract assets and investment securities, revisions to estimated profitability on long-term product service and other service agreements, incremental credit losses on receivables and debt securities, incremental losses related to our contingencies, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event.
In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.
Beginning in the first quarter of 2025, we changed the terminology used to report our earnings from “Earnings” to “Net income.” The change in terminology does not impact the amounts reported in the financial statements. Comparative periods have been renamed to reflect this change for consistency. We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings-per-share amounts are computed independently for net income from continuing operations, net income from discontinued operations and net income. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information.
The accompanying consolidated financial statements and notes are unaudited. The results reported in these financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. These financial statements should be read in conjunction with the financial statements, notes and significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2024.
NOTE 2. DISCONTINUED OPERATIONS. Our former GE Vernova and GE HealthCare businesses, our mortgage portfolio in Poland (Bank BPH) and other trailing assets and liabilities associated with prior dispositions are included in discontinued operations. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis.
GE Vernova. On April 2, 2024, we completed the previously announced separation of GE Vernova. The separation was structured as a tax-free spin-off and was achieved through the Company's pro-rata distribution of all the outstanding shares of GE Vernova to holders of the Company's common stock. In connection with the GE Vernova separation, the historical results of GE Vernova and certain assets and liabilities included in the separation are reported in GE Aerospace consolidated financial statements as discontinued operations. In addition, the Company contributed $515 million of cash to fund GE Vernova’s future operations such that GE Vernova’s cash balance on the date of separation was $4,242 million.
We have continuing involvement with GE Vernova primarily through ongoing sales of products, a transition services agreement, through which GE Aerospace and GE Vernova continue to provide certain services to each other for a period of time following the separation, a separation and distribution agreement, including performance and financial guarantees, a tax matters agreement and a trademark licensing agreement. For the six months ended June 30, 2025, we had direct and indirect sales of $154 million to GE Vernova, primarily related to engine sales and parts. We collected net cash of $401 million related to the transition services agreement and sales of engines and parts for the six months ended June 30, 2025.
GE HealthCare. On January 3, 2023, we completed the previously announced separation of our HealthCare business, into a separate, independent, publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). The separation was structured as a tax-free spin-off and was achieved through the Company's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of the Company's common stock. In connection with the separation, the historical results of GE HealthCare and certain assets and liabilities included in the separation are reported in GE Aerospace consolidated financial statements as discontinued operations.
We had continuing involvement with GE HealthCare primarily through a transition services agreement, which was completed as of December 31, 2024, through which GE Aerospace and GE HealthCare continued to provide certain services to each other for a period of time following the separation. In addition, we have a tax matters agreement and a trademark licensing agreement. For the six months ended June 30, 2025, we collected net cash of $46 million related to these activities, primarily in the first quarter of 2025.
2025 2Q FORM 10-Q 19
Bank BPH. As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. The estimate of total losses for borrower litigation at Bank BPH was $2,520 million and $2,461 million as of June 30, 2025 and December 31, 2024, respectively, with the increase driven by foreign exchange movements. No incremental contributions from GE Aerospace were required during the six months ended June 30, 2025. For further information about factors that are relevant to the estimate of total losses for borrower litigation at Bank BPH, see Note 22. Future changes or adverse developments could increase our estimate of total losses and potentially require future cash contributions to Bank BPH.
The Bank BPH financing receivable portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields and estimates with respect to ongoing borrower litigation. At June 30, 2025, the total portfolio hadno carrying value, net of a valuation allowance. Income (loss) related to ongoing borrower litigation waszero in pre-tax charges for both the three and six months ended June 30, 2025, and 2024, respectively.
| RESULTS OF DISCONTINUED OPERATIONSThree months ended June 30 · 2025 · 2024 | ||||||
|---|---|---|---|---|---|---|
| GE Vernova · Bank BPH & Other · Total · GE Vernova · Bank BPH & Other · Total | ||||||
| Total revenue | $— | $— | $— | $— | $— | $— |
| Cost of equipment and services sold | — | — | — | — | — | — |
| Other income, costs and expenses | 2 | 5 | 6 | (11) | 8 | (2) |
| Net income (loss) of discontinued operations before income taxes | 2 | 5 | 6 | (11) | 8 | (2) |
| Benefit (provision) for income taxes | — | 15 | 15 | (58) | (3) | (61) |
| Net income (loss) of discontinued operations, net of taxes | 1 | 19 | 21 | (68) | 5 | (63) |
| Gain (loss) on disposal before income taxes | — | — | — | — | 9 | 9 |
| Benefit (provision) for income taxes | — | — | — | — | — | — |
| Gain (loss) on disposal, net of taxes | — | — | — | — | 9 | 9 |
| Net income (loss) from discontinued operations, net of taxes | $1 | $19 | $21 | $(68) | $14 | $(54) |
| RESULTS OF DISCONTINUED OPERATIONSSix months ended June 30 · 2025 · 2024 | ||||||
|---|---|---|---|---|---|---|
| GE Vernova · Bank BPH & Other · Total · GE Vernova · Bank BPH & Other · Total | ||||||
| Total revenue | $— | $— | $— | $7,244 | $— | $7,244 |
| Cost of equipment and services sold | — | — | — | (6,074) | — | (6,074) |
| Other income, costs and expenses | 1 | 4 | 6 | (1,299) | 14 | (1,284) |
| Net income (loss) of discontinued operations before income taxes | 1 | 4 | 6 | (129) | 14 | (115) |
| Benefit (provision) for income taxes | — | 22 | 22 | (132) | 3 | (129) |
| Net income (loss) of discontinued operations, net of taxes | 1 | 26 | 27 | (261) | 17 | (243) |
| Gain (loss) on disposal before income taxes | — | 4 | 4 | — | 11 | 11 |
| Benefit (provision) for income taxes | — | — | — | — | — | — |
| Gain (loss) on disposal, net of taxes | — | 4 | 4 | — | 11 | 11 |
| Net income (loss) from discontinued operations, net of taxes | $1 | $30 | $31 | $(261) | $29 | $(232) |
202025 2Q FORM 10-Q
| ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Cash, cash equivalents and restricted cash(a) | $1,429 | $1,327 |
| Current receivables | 28 | 13 |
| Property, plant and equipment - net | 33 | 40 |
| All other assets | 505 | 438 |
| Deferred income taxes | 11 | 24 |
| Assets of discontinued operations(b) | $2,007 | $1,841 |
| Accounts payable | $33 | $30 |
| Non-current compensation and benefits | 33 | 33 |
| All other liabilities | 1,297 | 1,254 |
| Liabilities of discontinued operations(b) | $1,362 | $1,317 |
(a) Included $1,427 million and $1,324 million of cash, cash equivalents and restricted cash related to Bank BPH as of June 30, 2025 and December 31, 2024, respectively.
(b) Included $1,589 million and $1,594 million of valuation allowances against financing receivables held for sale, of which $1,503 million and $1,517 million related to estimated borrower litigation losses, and $1,017 million and $944 million in All other liabilities related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio as of June 30, 2025 and December 31, 2024, respectively. Accordingly, total estimated losses related to borrower litigation were $2,520 million and $2,461 million as of June 30, 2025 and December 31, 2024, respectively, with the increase driven by foreign exchange movements. The valuation allowance completely offsets the financing receivables balance as of June 30, 2025 and December 31, 2024.
NOTE 3. INVESTMENT SECURITIES. Current investment securities includeour senior note from AerCap, for which we have adopted the fair value option and matures in the fourth quarter of 2025, with a fair value of $998 million and $982 million at June 30, 2025 and December 31, 2024, respectively.
Substantially all of our non-current investment securities are held within our run-off insurance operations and support the long-duration insurance liabilities. The portfolio includes debt securities, of which all are substantially investment grade, and are classified as available-for-sale.
| June 30, 2025 | December 31, 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| Amortizedcost | Grossunrealizedgains | Grossunrealizedlosses | Estimatedfair value | Amortizedcost | Grossunrealizedgains | Grossunrealizedlosses | Estimatedfair value | |
| Debt | ||||||||
| U.S. corporate | $27,725 | $722 | $(2,164) | $26,283 | $28,456 | $546 | $(2,309) | $26,692 |
| Non-U.S. corporate | 2,925 | 33 | (279) | 2,679 | 2,970 | 23 | (302) | 2,691 |
| State and municipal | 2,487 | 40 | (216) | 2,311 | 2,409 | 22 | (235) | 2,196 |
| Mortgage and asset-backed | 5,448 | 64 | (149) | 5,363 | 5,007 | 47 | (183) | 4,870 |
| Government and agencies | 1,121 | 5 | (115) | 1,010 | 1,180 | 4 | (118) | 1,066 |
| Equity | 240 | — | — | 240 | 225 | — | — | 225 |
| Non-current investment securities | $39,946 | $863 | $(2,923) | $37,887 | $40,248 | $641 | $(3,148) | $37,741 |
The amortized cost of debt securities excludes accrued interest of $467 million and $473 million at June 30, 2025 and December 31, 2024, respectively, which is reported in All other current assets.
The estimated fair value of non-current investment securities at June 30, 2025 increased since December 31, 2024, primarily due to lower market yields partially offset by net proceeds from debt/equity securities sales and redemptions.
Total estimated fair value of debt securities in an unrealized loss position were $19,794 million and $21,876 million, of which $13,707 million and $14,011 million had gross unrealized losses of $(2,652) million and $(2,795) million and have been in a loss position for 12 months or more at June 30, 2025 and December 31, 2024, respectively. The majority of our U.S. and non-U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology, communication and energy industries. The majority of our commercial mortgage-backed securities and asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis.
2025 2Q FORM 10-Q 21
| Three months ended June 30 | Six months ended June 30 | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV) | $5 | $(378) | $10 | $62 |
| Proceeds from debt/equity securities sales and redemptions | 552 | 1,083 | 1,224 | 4,278 |
| Gross realized gains on debt securities | 5 | 9 | 10 | 17 |
| Gross realized losses and impairments on debt securities | (10) | (28) | (17) | (38) |
Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at June 30, 2025 are as follows:
| Amortized cost | Estimated fair value | |
|---|---|---|
| Within one year | $843 | $843 |
| After one year through five years | 3,837 | 3,910 |
| After five years through ten years | 5,123 | 5,251 |
| After ten years | 24,456 | 22,279 |
We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations.
The majority of our non-current investment securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $4,348 million and $5,074 million, including the AerCap senior note, are classified within Level 3, as significant inputs to their valuation models are unobservable at June 30, 2025 and December 31, 2024, respectively. During the six months ended June 30, 2025, $1,144 million was transferred out of Level 3 related to increases in the observability of external information used in determining fair value in our run-off insurance operations and primarily included certain investments in private placement U.S. and non-U.S. corporate debt securities. During the six months ended June 30, 2025 there were no significant transfers into Level 3 and during the six months ended June 30, 2024, there were no significant transfers into or out of Level 3.
In addition to the equity securities described above, we held $1,680 million and $1,439 million of equity securities without RDFV including $1,651 million and $1,410 million within our run-off insurance operations at June 30, 2025 and December 31, 2024, respectively, that are classified within All other assets in our Statement of Financial Position. Fair value adjustments, net of impairments, recorded in income were $62 million and $29 million and $100 million and $63 million for the three and six months ended June 30, 2025, and 2024, respectively. These are primarily limited partnership investments in private equity, infrastructure and real estate funds that are measured at net asset value per share (or equivalent) as a practical expedient to estimated fair value and are excluded from the fair value hierarchy. These limited partnership investments are generally not eligible for redemption and generally cannot be sold without approval of the general partner. Distributions from each fund will be received as the underlying investments of the funds are liquidated at the discretion of the general partner. These investments are generally considered illiquid and our ability to receive the most recent net asset value in a sale would be determined by external market factors.
NOTE 4. CURRENT AND LONG-TERM RECEIVABLES
| CURRENT RECEIVABLES | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Customer receivables | $8,305 | $7,385 |
| Revenue sharing and other partner receivables(a) | 1,272 | 1,113 |
| Non-income based tax receivables | 131 | 128 |
| Supplier advances | 673 | 546 |
| Receivables from disposed businesses | 57 | 99 |
| Other sundry receivables | 151 | 162 |
| Allowance for credit losses | (76) | (106) |
| Total current receivables | $10,512 | $9,327 |
(a) Revenue sharing and other partner receivables are primarily amounts due from revenue sharing partners who participate in engine programs by developing and supplying certain engine components through the life of the program or other partners who support our production or aftermarket activities. The revenue sharing partners share in program revenue, receive a share of customer progress payments and share costs related to discounts and warranties.
Sales of customer receivables. From time to time, the Company sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. The Company sold current customer receivables to third parties and subsequently collected $101 million and $240 million in thesix months ended June 30, 2025 and 2024, respectively, related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in the Commercial Engines & Services business, the Company has no continuing involvement; fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice value and due date.
222025 2Q FORM 10-Q
| LONG-TERM RECEIVABLES | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Long-term customer receivables | $122 | $122 |
| Supplier advances | 81 | 50 |
| Sundry receivables | 122 | 106 |
| Allowance for credit losses | (112) | (85) |
| Total long-term receivables | $214 | $194 |
NOTE 5. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Raw materials and work in process | $8,690 | $7,372 |
| Finished goods | 1,590 | 1,459 |
| Deferred inventory costs(a) | 1,017 | 932 |
| Inventories, including deferred inventory costs | $11,297 | $9,763 |
(a) Represents deferred labor and overhead costs on time and material service contracts and other costs of products and services for which the criteria for revenue recognition has not yet been met.
NOTE 6. PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Original cost | $16,565 | $15,894 |
| Less accumulated depreciation and amortization | (10,097) | (9,673) |
| Right-of-use operating lease assets | 1,056 | 1,057 |
| Property, plant and equipment – net | $7,523 | $7,277 |
| DEPRECIATION AND AMORTIZATION EXPENSE | Three months ended June 30 | Six months ended June 30 | ||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Commercial Engines & Services | $105 | $88 | $203 | $179 |
| Defense & Propulsion Technologies | 39 | 37 | 73 | 75 |
| Corporate and Other (including supply chain) | 75 | 75 | 153 | 147 |
| Total | $219 | $199 | $428 | $401 |
Operating Lease Liabilities. Our current operating lease liabilities, included in All other current liabilities in our Statement of Financial Position were $287 million and $283 million as of June 30, 2025 and December 31, 2024, respectively. Our non-current operating lease liabilities, included in All other liabilities in our Statement of Financial Position, were $823 million and $822 million as of June 30, 2025 and December 31, 2024, respectively. Expense on our operating lease portfolio, primarily from our long-term fixed leases, was $99 million and $128 million for the three months ended June 30, 2025 and 2024, respectively, and $197 million and $240 million for the six months ended June 30, 2025 and 2024, respectively.
NOTE 7. GOODWILL AND OTHER INTANGIBLE ASSETS
| Commercial Engines & Services | Defense & Propulsion Technologies | Total | |
|---|---|---|---|
| Balance at January 1, 2025 | $6,341 | $2,197 | $8,538 |
| Goodwill acquisition | — | 142 | 142 |
| Goodwill adjustments(a) | 266 | 59 | 326 |
| Balance at June 30, 2025 | $6,607 | $2,398 | $9,006 |
(a) Goodwill adjustments are primarily related to foreign currency exchange.
We assess the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. In the second quarter of 2025, we did not identify any reporting units that required an interim impairment test.
Other intangible assets increased $79 million during the six months ended June 30, 2025, primarily as a result of acquisitions within our Defense & Propulsion Technologies segment. All other intangible assets are subject to amortization. Consolidated amortization expense was $93 million and $83 million in the three months ended and $182 million and $172 million in the six months ended June 30, 2025 and 2024, respectively.
2025 2Q FORM 10-Q 23
NOTE 8. CONTRACT AND OTHER DEFERRED ASSETS, CONTRACT LIABILITIES AND DEFERRED INCOME & PROGRESS COLLECTIONS
Contract assets (liabilities) and other deferred assets (income), on a net basis, increased the net liability position by $364 million for the six months ended June 30, 2025, primarily due to an increase in long-term service agreements liabilities of $387 million. In aggregate, the net liability for long-term service agreements increased primarily due to billings of $4,359 million and net unfavorable changes in estimated profitability of $271 million, including quarterly updates to contract margins and an estimated impact from tariffs, primarily in Commercial Engines & Services, partially offset by revenue recognized of $4,284 million. Revenue recognized for contracts included in a liability position at the beginning of the year were $3,892 million and $3,537 million for the six months ended June 30, 2025 and 2024, respectively.
| CONTRACT ASSETS, LIABILITIES AND OTHER DEFERRED ASSETS AND INCOME | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Long-term service agreements | $2,403 | $2,374 |
| Equipment and other service agreements | 656 | 609 |
| Current contract assets | $3,059 | $2,982 |
| Nonrecurring engineering costs(a) | $2,449 | $2,438 |
| Customer advances and other(b) | 2,354 | 2,393 |
| Contract and other deferred assets | 4,803 | 4,831 |
| Total contract and other deferred assets | $7,862 | $7,814 |
| Long-term service agreement liabilities | $9,381 | $8,994 |
| Current deferred income | 358 | 359 |
| Contract liabilities and current deferred income | $9,738 | $9,353 |
| Non-current deferred income | 1,040 | 1,013 |
| Total contract liabilities and deferred income | $10,778 | $10,366 |
| Contract assets (liabilities) and other deferred assets (income) | $(2,916) | $(2,552) |
(a) Includes contract fulfillment costs for engineering and development incurred prior to production for equipment production contracts, primarily within our Defense & Propulsion Technologies segment, which are amortized ratably over each unit produced. We assess the recoverability of these costs and if we determine the costs are no longer probable of recovery, the asset is impaired.
(b) Includes amounts due from customers within our Commercial Engines & Services segment for the sales of engines, spare parts and services, which we collect through fixed or usage-based billings from the sale of spare parts and servicing of equipment under long-term service agreements.
Progress collections increased $330 million in the six months ended June 30, 2025 primarily due to increased collections at Defense & Propulsion Technologies.
NOTE 9. ALL OTHER ASSETS. All other current assets and All other assets primarily include equity method investments, Insurance cash and cash equivalents, receivables and other investments in our run-off insurance operations, pension surplus and prepaid taxes and other deferred charges. All other non-current assets increased $1,092 million in the six months ended June 30, 2025, due to an increase in equity method and other investments, primarily at our run-off insurance operations, of $376 million, an increase in Insurance cash and cash equivalents of $257 million, an increase in Insurance receivables of $243 million and an increase in pension surplus of $104 million. Insurance cash and cash equivalents was $1,191 million and $934 million at June 30, 2025 and December 31, 2024, respectively.
NOTE 10. BORROWINGS
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Current portion of long-term borrowings | ||
| Senior notes | $1,817 | $1,952 |
| Subordinated notes and other | 47 | 87 |
| Other short-term borrowings | 25 | — |
| Total short-term borrowings | $1,889 | $2,039 |
| Senior notes | 14,991 | 15,467 |
| Subordinated notes | 1,447 | 1,330 |
| Other | 560 | 437 |
| Total long-term borrowings | $16,998 | $17,234 |
| Total borrowings | $18,886 | $19,273 |
See Note 20 for further information about borrowings and associated hedges.
242025 2Q FORM 10-Q
NOTE 11. ACCOUNTS PAYABLE
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| Trade payables | $7,315 | $6,254 |
| Supply chain finance programs(a) | 1,564 | 1,259 |
| Sundry payables | 616 | 397 |
| Accounts payable | $9,495 | $7,909 |
(a) During the first quarter of 2025 and fourth quarter of 2024, GE Aerospace made prepayments of $199 million and $198 million, respectively, related to the supply chain finance programs. There wereno prepayments made in the second quarter of 2025.
We facilitate voluntary supply chain finance programs with third parties, which provide participating suppliers the opportunity to sell their GE Aerospace receivables to third parties at the sole discretion of both the suppliers and the third parties. Total supplier invoices paid through these third-party programs were $1,545 million and $1,799 million for the six months ended June 30, 2025 and 2024, respectively. GE Aerospace has no costs associated with this program.
NOTE 12. INSURANCE LIABILITIES AND ANNUITY BENEFITS. Insurance liabilities and annuity benefits are comprised of obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenue of $872 million and $871 million, profit was $147 million and $170 million and net income was $118 million and $134 million for the three months ended June 30, 2025 and 2024, respectively. For the six months ended June 30, 2025 and 2024, revenues were $1,806 million and $1,750 million, profit was $353 million and $370 million and net income was $280 million and $292 million, respectively. These operations were primarily supported by investment securities, substantially all debt securities, of $37,512 million and $37,352 million, limited partnerships of $4,777 million and $4,321 million, a diversified commercial mortgage loan portfolio collateralized by first liens on U.S. commercial real estate properties of $1,877 million and $1,887 million (net of allowance for credit losses of $45 million and $46 million), and residential mortgage loans of $314 million and $251 million (net of allowance for credit losses of an insignificant amount), as of June 30, 2025 and December 31, 2024, respectively. As of June 30, 2025, the commercial mortgage loan portfolio hadone delinquent loan, one non-accrual loan and about one-third of the portfolio was held in the office sector, which had a weighted average loan-to-value ratio of 73%, debt service coverage of 1.8, and an insignificant amount of scheduled maturities through 2026. A summary of our insurance liabilities and annuity benefits is presented below.
| June 30, 2025 | Long-term care | Structured settlement annuities | Life | Other contracts | Total |
|---|---|---|---|---|---|
| Future policy benefit reserves | $25,051 | $8,382 | $994 | $337 | $34,764 |
| Investment contracts | — | 682 | — | 591 | 1,274 |
| Other | — | — | 111 | 597 | 708 |
| Total | $25,051 | $9,064 | $1,104 | $1,526 | $36,745 |
| Future policy benefit reserves | $24,675 | $8,426 | $1,018 | $357 | $34,476 |
|---|---|---|---|---|---|
| Investment contracts | — | 719 | — | 621 | 1,340 |
| Other | — | — | 116 | 277 | 394 |
| Total | $24,675 | $9,145 | $1,134 | $1,254 | $36,209 |
2025 2Q FORM 10-Q 25
The following tables summarize balances of and changes in future policy benefit reserves.
| June 30, 2025 | June 30, 2024 | |||||
|---|---|---|---|---|---|---|
| Present value of expected net premiums | Long-term care | Structured settlement annuities | Life | Long-term care | Structured settlement annuities | Life |
| Balance, beginning of year | $4,144 | $— | $4,318 | $4,063 | $— | $4,803 |
| Beginning balance at locked-in discount rate | 3,991 | — | 4,415 | 3,745 | — | 4,773 |
| Effect of changes in cash flow assumptions | 16 | — | — | 16 | — | — |
| Effect of actual variances from expected experience | 12 | — | 8 | (26) | — | (34) |
| Adjusted beginning of year balance | 4,018 | — | 4,423 | 3,735 | — | 4,739 |
| Interest accrual | 108 | — | 92 | 101 | — | 90 |
| Net premiums collected | (197) | — | (148) | (196) | — | (140) |
| Effect of foreign currency | — | — | 130 | — | — | (91) |
| Ending balance at locked-in discount rate | 3,930 | — | 4,496 | 3,640 | — | 4,597 |
| Effect of changes in discount rate assumptions | 211 | — | (104) | 164 | — | (183) |
| Balance, end of period | $4,141 | $— | $4,392 | $3,803 | $— | $4,415 |
| Present value of expected future policy benefits | ||||||
| Balance, beginning of year | $28,820 | $8,426 | $5,336 | $30,895 | $9,357 | $5,921 |
| Beginning balance at locked-in discount rate | 27,448 | 8,301 | 5,411 | 27,144 | 8,561 | 5,847 |
| Effect of changes in cash flow assumptions | (68) | — | — | (10) | — | — |
| Effect of actual variances from expected experience | 152 | (6) | 24 | 7 | (25) | (51) |
| Adjusted beginning of year balance | 27,533 | 8,295 | 5,435 | 27,141 | 8,536 | 5,796 |
| Interest accrual | 748 | 217 | 112 | 738 | 222 | 110 |
| Benefit payments | (743) | (325) | (222) | (693) | (328) | (219) |
| Effect of foreign currency | — | — | 136 | — | — | (96) |
| Ending balance at locked-in discount rate | 27,537 | 8,187 | 5,461 | 27,185 | 8,429 | 5,591 |
| Effect of changes in discount rate assumptions | 1,654 | 195 | (75) | 1,920 | 271 | (166) |
| Balance, end of period | $29,192 | $8,382 | $5,386 | $29,105 | $8,700 | $5,424 |
| Net future policy benefit reserves | $25,051 | $8,382 | $994 | $25,301 | $8,700 | $1,010 |
| Less: Reinsurance recoverables, net of allowance for credit losses | (157) | — | (248) | (155) | — | (31) |
| Net future policy benefit reserves, after reinsurance recoverables | $24,895 | $8,382 | $746 | $25,146 | $8,700 | $979 |
| Weighted-average duration of liability (years)(a) | 11.3 | 10.1 | 5.3 | 12.1 | 10.7 | 5.4 |
| Weighted-average interest accretion rate | 5.6% | 5.4% | 5.3% | 5.6% | 5.4% | 5.2% |
| Current discount rate | 5.5% | 5.5% | 4.9% | 5.4% | 5.4% | 5.1% |
| Gross premiums or assessments recognized during period | $231 | $— | $163 | $242 | $— | $156 |
| Expected future gross premiums, undiscounted | 7,321 | — | 11,569 | 7,244 | — | 11,886 |
| Expected future gross premiums, discounted(a) | 4,694 | — | 5,303 | 4,665 | — | 5,323 |
| Expected future benefit payments, undiscounted | 61,410 | 18,249 | 10,442 | 62,387 | 18,937 | 10,730 |
| Expected future benefit payments, discounted(a) | 29,192 | 8,382 | 5,386 | 29,105 | 8,700 | 5,424 |
(a) Determined using the current discount rate as of June 30, 2025 and 2024.
As of June 30, 2025 and 2024, policyholders account balances totaled $1,499 million and $1,654 million, respectively. As our insurance operations are in run-off, changes in policyholder account balances for the six months ended June 30, 2025 and 2024 are primarily attributed to surrenders, withdrawals, and benefit payments of $211 million and $215 million, partially offset by net additions from separate accounts and interest credited of $134 million and $142 million, respectively. Interest on policyholder account balances is generally credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both June 30, 2025 and 2024.
In the third quarter, we will complete our annual review of future policy benefit reserves cash flow assumptions, except related claim expenses which remain locked-in. If the review concludes that the assumptions need to be updated, future policy benefit reserves will be adjusted retroactively to the ASU 2018-12 transition date based on the revised net premium ratio using actual historical experience, updated cash flow assumptions, and the locked-in discount rate with the effect of those changes recognized in current period earnings.
On February 3, 2025, we closed the Canadian life and health insurance portfolio reinsurance transaction that was announced in 2024. We received a ceding commission of $128 million and the gain was deferred and will be recognized over the remaining life of the policies or earlier if the underlying treaties are novated.
See Notes 3 and 9 for further information related to our run-off insurance operations.
262025 2Q FORM 10-Q
NOTE 13. POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present inthree categories; principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2024 for further information.
The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Operations.
| PRINCIPAL PENSION PLANS | Three months ended June 30 | Six months ended June 30 | ||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Service cost for benefits earned | $14 | $17 | $33 | $37 |
| Prior service cost amortization | (3) | 1 | (5) | 4 |
| Expected return on plan assets | (375) | (390) | (750) | (968) |
| Interest cost on benefit obligations | 326 | 315 | 651 | 768 |
| Net actuarial gain amortization | (125) | (103) | (253) | (257) |
| Net periodic expense (income) | $(163) | $(160) | $(324) | $(416) |
| Less discontinued operations | $— | $— | $— | $(88) |
| Continuing operations - net periodic expense (income) | $(163) | $(160) | $(324) | $(328) |
Principal retiree benefit plans income was $17 million and $21 million for the three months ended June 30, 2025 and 2024, and $32 million and $57 million for the six months ended June 30, 2025 and 2024, respectively. Principal retiree benefit plans income from continuing operations was $21 million and $43 million for the three and six months ended June 30, 2024, respectively.
We have a defined contribution plan for eligible U.S. employees that provides employer contributions, which were $59 million and $74 million for the three months ended June 30, 2025 and 2024,and $139 million and $163 million for the six months ended June 30, 2025 and 2024, respectively. Employer contributions from continuing operations were $74 million and $128 million for the three and six months ended June 30, 2024, respectively.
NOTE 14. SALES DISCOUNTS AND ALLOWANCES & ALL OTHER LIABILITIES.
Sales discounts and allowances increased $447 million in the six months ended June 30, 2025, primarily due to accruals on product reserves, spare part discounts and engine shipments outpacing payments to airline customers in Commercial Engines & Services.
All other current liabilities and All other liabilities primarily includes employee compensation and benefits, equipment project and commercial liabilities, income taxes payable and uncertain tax positions, environmental, health and safety remediations, operating lease liabilities (see Note 6) and product warranties (see Note 22). All other current liabilities decreased $525 million in the six months ended June 30, 2025, primarily due to a decrease in employee compensation and benefits of $398 million primarily driven by payments of employee benefit liabilities, and a decrease in equipment projects and other commercial liabilities of $124 million. All other liabilities increased $128 million in the six months ended June 30, 2025, primarily due to increases in uncertain and other income taxes and related liabilities of $82 million and environmental, health and safety liabilities of $75 million.
NOTE 15. INCOME TAXES. Our effective income tax rate was 14.5% and 10.7% for the six months ended June 30, 2025 and 2024, respectively. The tax rate for 2025 was reduced compared to the U.S. statutory rate of 21% primarily due to U.S. business tax credit benefits, tax effects of favorable audit resolutions, realized foreign tax credits benefits on the reinsurance transaction (see Note 12), and tax benefits on equity compensation. The tax rate for 2024 was reduced compared to the U.S. statutory rate of 21% primarily due to separation income tax benefit associated with an increase in net state deferred tax assets that are likely to be utilized after the spin of GE Vernova, U.S. business tax credit benefits, and lower tax on global activities.
On July 4, 2025, the reconciliation bill, commonly referred to as the One Big Beautiful Bill Act (OBBB) was signed into law, which includes a broad range of tax reform provisions that may affect the Company's financial results. The OBBB allows an elective deduction for domestic Research and Development (R&D), a reinstatement of elective 100% first-year bonus depreciation, and a more favorable tax rate on Foreign-derived Deduction Eligible Income and income from non-U.S. subsidiaries (Net CFC Tested Income), among other provisions. The Company is currently evaluating the impact of these provisions which could affect the Company's effective tax rate and deferred tax assets in 2025 and future periods. A quantitative estimate of the specific financial effects cannot be reasonably determined at this time due to the complexity of the changes in the tax reform. The impact of those tax provisions in the OBBB will depend on our facts in each year and anticipated guidance from the U.S. Department of the Treasury.
2025 2Q FORM 10-Q 27
The OECD (Organisation for Economic Co-operation and Development) has proposed a global minimum tax of 15% of reported profits (Pillar 2) that has been agreed upon in principle by over 140 countries. Since the proposal, many countries incorporated Pillar 2 model rule concepts into their domestic laws. Although the model rules provide a framework for applying the minimum tax, countries may enact Pillar 2 slightly differently than the model rules and on different timelines and may adjust domestic tax incentives in response to Pillar 2. In addition, in January 2025, the United States issued an executive order announcing opposition to aspects of these rules. In June 2025, the G7 agreed to exclude U.S. Multi-National Entities (MNEs) from certain aspects of the Pillar 2 global minimum tax rules (the G7 Statement) in exchange for the U.S. not imposing retaliatory taxes in the OBBB. We will continue to monitor the G7 Statement, which has not yet been incorporated into the OECD framework. As countries continue to enact and refine the Pillar 2 rules, we will evaluate the impact on our financial position. In 2025, we expect to incur $0.1 billion in connection with the incorporation of the Pillar 2 model rules.
The Internal Revenue Service (IRS) is currently auditing our consolidated U.S. income tax returns for 2016-2020.
The following table presents our net deferred tax assets and net deferred tax liabilities attributable to different tax jurisdictions or different tax paying components.
| DEFERRED INCOME TAXES | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Total assets | $7,289 | $7,479 |
| Total liabilities | (399) | (368) |
| Net deferred income tax asset | $6,890 | $7,111 |
NOTE 16. SHAREHOLDERS’ EQUITY
| ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) | Three months ended June 30 | Six months ended June 30 | ||
|---|---|---|---|---|
| (Dividends per share in dollars) | 2025 | 2024 | 2025 | 2024 |
| Beginning balance | $(1,478) | $(3,658) | $(1,472) | $(3,623) |
| AOCI before reclasses – net of taxes of $(100), $(39), $(140) and $(13) | (12) | 29 | (19) | (6) |
| Reclasses from AOCI – net of taxes of $—, $103, $— and $103(a) | — | 2,094 | — | 2,094 |
| AOCI | (12) | 2,123 | (19) | 2,087 |
| Less AOCI attributable to noncontrolling interests | — | (22) | — | (22) |
| Currency translation adjustments AOCI | $(1,491) | $(1,514) | $(1,491) | $(1,514) |
| Beginning balance | $531 | $1,586 | $665 | $1,786 |
| AOCI before reclasses – net of taxes of $(21), $(12), $(25) and $(4) | (70) | (54) | (85) | (83) |
| Reclasses from AOCI – net of taxes of $(34), $(156), $(69) and $(208)(a) | (122) | (736) | (241) | (904) |
| AOCI | (192) | (790) | (325) | (987) |
| Less AOCI attributable to noncontrolling interests | — | (9) | — | (7) |
| Benefit plans AOCI | $338 | $806 | $338 | $806 |
| Beginning balance | $(1,667) | $(1,412) | $(1,985) | $(959) |
| AOCI before reclasses – net of taxes of $39, $(92), $125 and $(208) | 114 | (341) | 437 | (806) |
| Reclasses from AOCI – net of taxes of $2, $13, $1 and $12 | (4) | 37 | (9) | 48 |
| AOCI | 110 | (304) | 428 | (758) |
| Less AOCI attributable to noncontrolling interests | — | 12 | — | 12 |
| Investment securities and cash flow hedges AOCI | $(1,557) | $(1,727) | $(1,557) | $(1,727) |
| Beginning balance | $(1,118) | $(2,119) | $(1,070) | $(3,354) |
| AOCI before reclasses – net of taxes of $(52), $138, $(65) and $466 | (196) | 518 | (244) | 1,753 |
| AOCI | (196) | 518 | (244) | 1,753 |
| Long-duration insurance contracts AOCI | $(1,314) | $(1,601) | $(1,314) | $(1,601) |
| AOCI at June 30 | $(4,024) | $(4,035) | $(4,024) | $(4,035) |
| Dividends declared per common share | $0.36 | $0.56 | $0.72 | $0.56 |
| (a) The total reclassifications from AOCI included $1,590 million, including currency translation of $2,174 million and benefit plans of $(584) million, net of taxes, in the second quarter of 2024 related to the separation of GE Vernova. | ||||
282025 2Q FORM 10-Q
Common stock. GE Aerospace common stock shares outstanding were 1,060,439,387 and 1,073,692,183 at June 30, 2025 and December 31, 2024, respectively. We repurchased 7.5 million shares for $1,653 million and 17.0 million shares for $3,566 million during the three and six months ended June 30, 2025. This included repurchases of 5.1 million shares for $1,213 million and 10.5 million shares for $2,325 million during the three and six months ended June 30, 2025 using accelerated stock repurchases as a mechanism to achieve planned repurchase volumes within the quarter during closed windows. The Company's share repurchase program does not obligate it to acquire any specific number of shares. Under this program, shares may be purchased in the open market, in privately negotiated transactions, under accelerated share repurchase programs or under plans complying with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended.
NOTE 17. EARNINGS PER SHARE (EPS) INFORMATION
| Three months ended June 30 · 2025 · 2024 | |||||
|---|---|---|---|---|---|
| (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) · Diluted · Basic · Diluted · Basic | |||||
| Net income (loss) from continuing operations attributable to common shareholders | $2,007 | $2,008 | $1,320 | $1,320 | |
| Net income (loss) from discontinued operations | 21 | 21 | (54) | (54) | |
| Net income (loss) attributable to common shareholders | 2,028 | 2,028 | 1,266 | 1,266 | |
| Shares of common stock outstanding | 1,063 | 1,063 | 1,089 | 1,089 | |
| Employee compensation-related shares (including stock options) | 7 | — | 11 | — | |
| Total average equivalent shares | 1,071 | 1,063 | 1,100 | 1,089 | |
| EPS from continuing operations | $1.87 | $1.89 | $1.20 | $1.21 | |
| EPS from discontinued operations | 0.02 | 0.02 | (0.05) | (0.05) | |
| Net EPS | 1.89 | 1.91 | 1.15 | 1.16 | |
| Potentially dilutive securities(a) | 2 | 6 | |||
| Six months ended June 30 · 2025 · 2024 | |||||
|---|---|---|---|---|---|
| (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) · Diluted · Basic · Diluted · Basic | |||||
| Net income (loss) from continuing operations attributable to common shareholders | 3,975 | 3,975 | 3,061 | 3,061 | |
| Net income (loss) from discontinued operations | 31 | 31 | (256) | (256) | |
| Net income (loss) attributable to common shareholders | 4,006 | 4,006 | 2,805 | 2,805 | |
| Shares of common stock outstanding | 1,067 | 1,067 | 1,089 | 1,089 | |
| Employee compensation-related shares (including stock options) | 8 | — | 11 | — | |
| Total average equivalent shares | 1,074 | 1,067 | 1,100 | 1,089 | |
| EPS from continuing operations | $3.70 | $3.73 | $2.78 | $2.81 | |
| EPS from discontinued operations | 0.03 | 0.03 | (0.23) | (0.23) | |
| Net EPS | 3.73 | 3.76 | 2.55 | 2.58 | |
| Potentially dilutive securities(a) | 2 | 9 | |||
(a) Outstanding stock awards not included in the computation of diluted earnings per share because their effect was antidilutive.
Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and historically have been included in the calculation pursuant to the two-class method. For the three and six months ended June 30, 2025, and the comparative period in 2024, and the Company calculates earnings per share using the treasury stock method.
NOTE 18. OTHER INCOME (LOSS)
| Three months ended June 30 | Six months ended June 30 | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Investment in GE HealthCare realized and unrealized gain (loss) | $— | $(397) | $— | $219 |
| AerCap note unrealized gain (loss) | 3 | 3 | 17 | 15 |
| Gains (losses) on retained and sold ownership interests | $3 | $(394) | $17 | $234 |
| Other net interest and investment income (loss) | 160 | 200 | 334 | 429 |
| Licensing and royalty income | 41 | 51 | 84 | 107 |
| Equity method income | 38 | 34 | 76 | 79 |
| Other items | 55 | 46 | 89 | 95 |
| Total other income (loss) | $298 | $(63) | $600 | $944 |
2025 2Q FORM 10-Q 29
NOTE 19. RESTRUCTURING CHARGES AND SEPARATION COSTS
RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate & Other. Separately, in our reported segment results, significant, higher-cost restructuring programs, primarily related to the separations, are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate & Other.
| RESTRUCTURING AND OTHER CHARGES | Three months ended June 30 | Six months ended June 30 | ||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Workforce reductions | $20 | $42 | $19 | $108 |
| Plant closures & associated costs and other asset write-downs | 7 | 5 | 10 | 24 |
| Acquisition/disposition net charges and other | — | 36 | — | 38 |
| $27 | $84 | $29 | $170 | |
| Cost of equipment/services | $— | $— | $3 | $1 |
| Selling, general and administrative expenses | 27 | 84 | 26 | 169 |
| Total restructuring and other charges | $27 | $84 | $29 | $170 |
| Restructuring and other cash expenditures(a) | $16 | $24 | $55 | $99 |
(a) Primarily related to employee severance payments.
The restructuring liability as of June 30, 2025 and December 31, 2024 was $205 million and $242 million, respectively.
For the three and six months ended June 30, 2025 and 2024, restructuring and other charges for ongoing programs primarily included exit activities announced in the fourth quarter of 2022, reflecting lower Corporate & Other shared-service and footprint needs as a result of the GE HealthCare and GE Vernova spin-offs.
SEPARATION COSTS. In November 2021, the Company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aerospace, healthcare and energy. As discussed in Note 2, we completed this plan with the spin of GE Vernova in the second quarter of 2024. Post-separation, we expect to continue to incur operational and transition costs related to ongoing separation activities, including employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation to transition to a stand-alone public company. These costs are presented as separation costs in our Statement of Operations.
For the three months ended June 30, 2025 and 2024, we incurred pre-tax separation expense of $47 million and $75 million, recognized $10 million and $216 million of net tax benefits and paid $70 million and $407 million in cash, respectively. For 2024, the net tax benefits included deferred tax benefits associated with state tax attributes.
For the six months ended June 30, 2025 and 2024, we incurred pre-tax separation costs of $98 million and $334 million, recognized
$20 million and $251 million of net tax benefits, and paid $146 million and $572 million in cash, respectively, related to separation activities.
The pre-tax separation costs specifically identifiable to GE HealthCare and GE Vernova are reflected in discontinued operations. We incurred insignificant costs for both GE Healthcare and GE Vernova for the three months ended June 30, 2025, as well as for GE Vernova for the three months ended June 30, 2024. Additionally, we recognized $10 million in pre-tax income, incurred $2 million of net tax expense related to GE HealthCare and we paid $0 million and $38 million in cash related to GE HealthCare and GE Vernova, respectively, for the three months ended June 30, 2024.
For the six months ended June 30, 2024, we recognized $10 million in pre-tax income, incurred $2 million of net tax expense, and spent $9 million in cash, related to GE HealthCare. In addition, we incurred pre-tax separation costs of $97 million, recognized $20 million of net tax benefit and paid $121 million in cash related to GE Vernova for the six months ended June 30, 2024.
NOTE 20. FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered Level 3 and substantially all these liabilities’ fair value are considered Level 2.
| June 30, 2025 · December 31, 2024 | |||||
|---|---|---|---|---|---|
| Carryingamount(net) · Estimatedfair value · Carryingamount(net) · Estimatedfair value | |||||
| Assets | Loans and other receivables(a) | $2,221 | $1,961 | $2,261 | $1,981 |
| Liabilities | Borrowings (Note 10) | 18,886 | 18,703 | 19,273 | 18,805 |
| Investment contracts(a) | 1,274 | 1,333 | 1,375 | 1,432 | |
(a) Primarily related to our run-off insurance operations. See Note 12 for further information.
Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and cash equivalents, investment securities (Note 3) and derivative financial instruments below.
302025 2Q FORM 10-Q
DERIVATIVES AND HEDGING. Per our policy, derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage risks related to foreign currency exchange (including foreign equity investments), interest rates and commodity prices.
We use our foreign currency debt and cross-currency interest rate swaps in net investment hedges to hedge currency exposures related to our net investments in foreign operations. We use currency exchange contracts for cash flow hedges primarily to reduce or eliminate the effects of foreign exchange rate changes. Gains and losses on derivatives used in qualified hedges are initially recognized in our Statement of Other Comprehensive Income (Loss) except for interest on cross-currency interest rate swaps. For cross-currency interest rate swaps in a qualified hedging relationships, we recognize the periodic interest settlements within Interest and other financial charges in the Statement of Operations, and the cash flows associated with these periodic interest settlements are classified as operating activities in the Statement of Cash Flows. Settlements from termination of all qualified hedges are classified in the Statement of Cash Flows reflecting the nature of the hedged items (e.g., investing activities for derivatives used to hedge net investments in our foreign operations).
We also use derivatives for economic hedges when we have exposures to currency exchange risk for which we are unable to meet the requirements for hedge accounting or when changes in the carrying amount of the hedged item are already recorded in income in the same period as the derivative making hedge accounting unnecessary. Even though the derivative is an effective economic hedge, there may be a net effect on income in each period due to differences in the timing of income recognition between the derivative and the hedged item.
| FAIR VALUE OF DERIVATIVES · June 30, 2025 · December 31, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gross Notional · All other current assets · All other current liabilities · Gross Notional · All other current assets · All other current liabilities | ||||||||
| Qualifying currency exchange contracts | $1,501 | $64 | $11 | $1,873 | $36 | $40 | ||
| Qualifying cross currency interest rate swaps(a) | 1,941 | — | 81 | 416 | 8 | — | ||
| Non-qualifying currency exchange contracts and other(b) | 6,903 | 242 | 29 | 6,759 | 199 | 91 | ||
| Gross derivatives | $10,345 | $306 | $121 | $9,047 | $243 | $131 | ||
| Netting and credit adjustments | $(68) | $(68) | $(55) | $(54) | ||||
| Net derivatives recognized in statement of financial position | $238 | $53 | $188 | $77 | ||||
(a) Gains (losses) on interest settlements related to cross-currency swaps included in our Statement of Operations were $6 million and $8 million for the three months and six months ended June 30, 2025, respectively. There wasno activity during the first two quarters of 2024.
(b) Gains (losses) included in our Statement of Operations were $181 million and $40 million for the three months ended June 30, 2025 and 2024, and $216 million and $62 million for six months ended June 30, 2025 and 2024, respectively, primarily in SG&A, driven by hedges of foreign currency exchange and deferred employee compensation. Substantially all of these amounts are offset by the remeasurement of the underlying exposure through income.
CASH FLOW HEDGES AND NET INVESTMENT HEDGES
| Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives · Amount of Gain (Loss) Reclassified from AOCI into Net Income | ||||||||
|---|---|---|---|---|---|---|---|---|
| Three months ended June 30 | Six months ended June 30 | Three months ended June 30 | Six months ended June 30 | |||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |
| Cash flow hedges(a) | $63 | $(14) | $110 | $(21) | $7 | $5 | $4 | $12 |
| Net investment hedges(b) | (479) | 68 | (692) | 150 | — | — | — | — |
(a) Primarily currency exchange contracts, and recognized in Costs of equipment or services sold in our Statement of Operations. We expect to reclassify a $64 million gain from AOCI to net income in the next 12 months contemporaneously with the income effects of the related forecasted transactions.
(b) The carrying value of foreign currency debt designated as net investment hedges was $4,892 million and $5,199 million at June 30, 2025 and December 31, 2024, respectively.
FAIR VALUE HEDGES. We used fair value hedges to hedge the effects of interest rate and currency changes on debt we issued. All fair value hedges were terminated in 2022 due to exposure management actions. The cumulative net gains related to hedging adjustments of $1,028 million and $1,037 million on discontinued hedges were included primarily inlong-term borrowings of $8,715 million and $8,387 million as of June 30, 2025 and December 31, 2024, respectively, and will continue to amortize into interest expense until the borrowings mature.
COUNTERPARTY CREDIT RISK. Our exposures to counterparties (including accrued interest) were $238 million and $188 million at June 30, 2025 and December 31, 2024, respectively. Counterparties' exposures to our derivative liability (including accrued interest), were $53 million and $77 million at June 30, 2025 and December 31, 2024, respectively.
2025 2Q FORM 10-Q 31
NOTE 21. VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $160 million and $141 million and liabilities of $137 million and $131 million at June 30, 2025 and December 31, 2024, respectively, in consolidated Variable Interest Entities (VIEs). These VIEs are primarily associated with a legacy business in Corporate & Other and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.
Our investments in unconsolidated VIEs were $8,718 million and $8,131 million at June 30, 2025 and December 31, 2024, respectively. Of these investments, $1,191 million and $1,280 million were in our U.S. tax equity portfolio, comprising equity method investments related to onshore renewable energy projects, at June 30, 2025 and December 31, 2024, respectively. In addition, $7,335 million and $6,665 million were in our run-off insurance operations, primarily comprised of equity method investments at June 30, 2025 and December 31, 2024, respectively. The increase in investments in unconsolidated VIEs in our run-off insurance operations reflects strategic initiatives to invest in higher-yielding asset classes. Our maximum exposure to loss with respect to unconsolidated VIEs is increased by our commitments to make additional investments in these entities described in Note 22.
NOTE 22. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES
COMMITMENTS. As of June 30, 2025, we had total investment commitments of $4,151 million, of which $4,020 million are related to investments by our run-off insurance operations in investment securities and other assets. Included within these commitments are obligations to make investments in unconsolidated VIEs of $3,912 million. We also have unfunded commitments for U.S. tax equity of $631 million. Additionally, we have committed to provide financing assistance of $2,590 million for future customer acquisitions of aircraft equipped with our engines. We believe there is a low probability of utilization of this financing assistance based on the terms under which the financing would be provided. See Note 21 for further information regarding VIEs.
GUARANTEES. Credit support and indemnification agreements - Continuing Operations. Following the separation of GE Vernova, we have remaining performance and bank guarantees on behalf of GE Vernova. To support GE Vernova in selling products and services globally, we often entered into contracts on behalf of GE Vernova or issued parent company guarantees or trade finance instruments supporting the performance of what were subsidiary legal entities transacting directly with customers, in addition to providing similar credit support for non-customer related activities of GE Vernova (collectively, "GE Aerospace credit support"). Under the Separation and Distribution Agreement (SDA), GE Vernova is obligated to use reasonable best efforts to replace us as the guarantor on or terminate all such credit support instruments. Until such termination or replacement, in the event of non-fulfillment of contractual obligations by the relevant obligor(s), we could be obligated to make payments under the applicable instruments. Under the SDA, GE Vernova is obligated to reimburse and indemnify us for any such payments. Beginning in 2025, GE Vernova is paying us a quarterly fee based on amounts related to the GE Aerospace credit support. We have recorded a reserve of $105 million for our stand ready to perform obligation. Our maximum aggregate exposure under the GE Aerospace credit support cannot be reasonably estimated given the breadth of the portfolio across each of the GE Vernova businesses except for certain financial guarantees and trade finance instruments with a maximum exposure of approximately $257 million. The underlying obligations are predominantly customer contracts that GE Vernova performs in the normal course of its business. We have no known instances historically where payments or performance were required by us under parent company guarantees relating to GE Vernova customer contracts. In connection with the spin-off of GE Vernova, under terms of the SDA, Transition Service Agreement (TSA) and Tax Matters Agreement (TMA), we have an obligation to indemnify GE Vernova for certain of its severance costs, environmental matters and tax matters of $137 million, of which $84 million is reserved.
We also have remaining obligations under the TMA with GE HealthCare to indemnify them for certain tax costs and other indemnifications of $55 million, which are fully reserved.
In addition, we have $183 million of other indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $55 million.
Credit support and indemnification agreements- Discontinued Operations. Following the separation of GE Vernova, we also have performance obligations related to GE Vernova nuclear decommissioning with a maximum aggregate exposure of $611 million for which we are fully indemnified. Also, under the SDA, TSA and TMA agreements we have obligations to indemnify GE Vernova for costs of certain environmental matters and tax matters of $34 million, which are fully reserved.
GE Aerospace also has obligations under the TMA to indemnify GE HealthCare for certain tax costs of $39 million, which are fully reserved.
We also have provided specific indemnities to other buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $451 million with related reserves of $49 million.
PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $636 million and $592 million at June 30, 2025 and December 31, 2024, respectively.
322025 2Q FORM 10-Q
LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 24 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2024 and Note 22 to the consolidated financial statements in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025; refer to those discussions for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated.
Shareholder and related lawsuits. Since November 2017, several putative shareholder class actions under the federal securities laws were filed against GE and certain affiliated individuals and consolidated into a single action currently pending in the U.S. District Court for the Southern District of New York (the Hachem case, also referred to as the Sjunde AP-Fonden case). The complaint against defendants GE and current and former GE executive officers alleged violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 related to insurance reserves and accounting for long-term service agreements and seeks damages on behalf of shareholders who acquired GE stock between February 27, 2013 and January 23, 2018. GE filed a motion to dismiss in December 2019. In January 2021, the court granted the motion to dismiss as to the majority of the claims. Specifically, the court dismissed all claims related to insurance reserves, as well as all claims related to accounting for long-term service agreements, with the exception of certain claims about historic disclosures related to factoring in the Power business that survive as to GE and its former CFO Jeffrey S. Bornstein. All other individual defendants have been dismissed from the case. In April 2022, the court granted the plaintiffs' motion for class certification for shareholders who acquired stock between February 26, 2016 and January 23, 2018. In September 2022, GE filed a motion for summary judgment on the plaintiffs' remaining claims, which the court denied in September 2023, except as to claims arising from disclosures made between November 2017 and January 2018. In April 2024, the court scheduled a trial date for November 2024. Consistent with the settlement in principle that we reported in October 2024, we signed an agreement with the plaintiffs in December 2024 to settle the matter for $362.5 million, which we deposited into an escrow account controlled by plaintiffs’ counsel. Final settlement of the matter was approved by the court on April 24, 2025.
Bank BPH. As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. For a number of years, we have observed an increase in the total number of lawsuits being brought against Bank BPH and other banks in Poland by current and former borrowers, and we expect this to continue in future reporting periods. As previously reported, GE and Bank BPH approved the adoption of a settlement program and recorded an additional charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH was $2,520 million and $2,461 million as of June 30, 2025 and December 31, 2024, respectively. This estimate accounts for the costs associated with borrowers who we estimate will participate in the settlement program, as well as estimates for the results of litigation with other borrowers, which in either case can exceed the value of the current loan balance, and represents our best estimate of the total losses we expect to incur over time informed by experience since adopting the program. However, there are a number of factors that could affect the estimate in the future; refer to the disclosure about Bank BPH in our Annual Report on Form 10-K for the year ended December 31, 2024.
ENVIRONMENTAL, HEALTH AND SAFETY MATTERS. Our operations involve or have involved the use, disposal and cleanup of substances regulated under environmental protection laws, including activities for a variety of matters related to GE businesses that have been discontinued or exited. We record reserves for obligations for ongoing and future environmental remediation activities, such as the Housatonic River cleanup, and for additional liabilities we expect to incur in connection with previously remediated sites, such as natural resource damages for the Hudson River where GE completed dredging in 2019. Additionally, like many other industrial companies, we and our subsidiaries are defendants in various lawsuits related to alleged exposure by workers and others to asbestos or other hazardous materials. Liabilities for environmental remediation and worker exposure claims exclude possible insurance recoveries. It is reasonably possible that our exposure will exceed amounts accrued. However, due to uncertainties about the status of laws, regulations, technology and information related to individual sites and lawsuits, such amounts are not reasonably estimable. Total reserves related to environmental remediation and worker exposure claims were $2,018 million and $2,003 million at June 30, 2025 and December 31, 2024 respectively.
2025 2Q FORM 10-Q 33
NOTE 23. SEGMENT INFORMATION & REMAINING PERFORMANCE OBLIGATION. We havetwo reportable segments andthree operating segments. Operating segments are aggregated into a reportable segment if the operating segments have similar quantitative economic characteristics and if the operating segments are similar in the following qualitative characteristics: (i) nature of products and services; (ii) nature of production processes; (iii) type or class of customer for their products and services; (iv) methods used to distribute the products or provide services; and (v) if applicable, the nature of the regulatory environment. We have aggregated Defense & Systems and Propulsion & Additive Technology into one reportable segment, Defense & Propulsion Technologies, based on similarity in economic characteristics, other qualitative factors and the objectives and principles of ASC 280, Segment Reporting. This is consistent with how our chief operating decision maker (CODM) allocates resources and makes decisions. Refer to our Annual Report on Form 10-K for the year ended December 31, 2024, for a description of our segments, further information regarding our determination of segment profit for continuing operations and our allocations of corporate costs to our segments.
The Company does not report total assets by segment for internal or external reporting purposes as the Company’s CODM does not assess performance, make strategic decisions, or allocate resources based on assets.
| EQUIPMENT & SERVICES REVENUE | ||||||
|---|---|---|---|---|---|---|
| Three months ended June 30 | 2025 | 2024 | ||||
| Equipment | Services | Total | Equipment | Services | Total | |
| Commercial Engines & Services | $1,931 | $6,059 | $7,990 | $1,427 | $4,705 | $6,132 |
| Defense & Propulsion Technologies | 1,233 | 1,329 | 2,563 | 1,071 | 1,329 | 2,401 |
| Total segment revenue | $3,164 | $7,389 | $10,553 | $2,498 | $6,034 | $8,533 |
| Six months ended June 30 | 2025 | 2024 | ||||
|---|---|---|---|---|---|---|
| Equipment | Services | Total | Equipment | Services | Total | |
| Commercial Engines & Services | $3,789 | $11,177 | $14,966 | $3,133 | $9,095 | $12,228 |
| Defense & Propulsion Technologies | 2,284 | 2,604 | 4,887 | 2,080 | 2,633 | 4,713 |
| Total segment revenue | $6,073 | $13,781 | $19,854 | $5,213 | $11,727 | $16,941 |
| EXPENSES, PROFIT AND INCOME | Three months ended June 30 | Six months ended June 30 | ||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Commercial Engines & Services | ||||
| Cost of revenue | $5,214 | $3,931 | $9,711 | $8,110 |
| Selling, general and administrative expenses | 438 | 413 | 860 | 839 |
| Research and development | 301 | 233 | 589 | 434 |
| Other segment expenses (income)(a) | (195) | (125) | (346) | (253) |
| Total Commercial Engines & Services expenses | 5,757 | 4,453 | 10,814 | 9,129 |
| Defense & Propulsion Technologies | ||||
| Cost of revenue | 1,884 | 1,776 | 3,609 | 3,557 |
| Selling, general and administrative expenses | 257 | 211 | 501 | 468 |
| Research and development | 71 | 75 | 143 | 142 |
| Other segment expenses (income)(a) | (12) | (5) | (23) | (54) |
| Total Defense & Propulsion Technologies expenses | 2,201 | 2,057 | 4,230 | 4,113 |
| Commercial Engines & Services | 2,232 | 1,679 | 4,152 | 3,098 |
| Defense & Propulsion Technologies | 362 | 344 | 658 | 600 |
| Total segment profit (loss) | 2,594 | 2,023 | 4,810 | 3,698 |
| Corporate & Other | (237) | (534) | (194) | (179) |
| Interest and other financial charges | (158) | (248) | (368) | (511) |
| Non-operating benefit income (cost) | 197 | 204 | 398 | 421 |
| Benefit (provision) for income taxes | (388) | (125) | (671) | (369) |
| Net income (loss) from continuing operations attributable to common shareholders | 2,008 | 1,320 | 3,975 | 3,061 |
| Net income (loss) from discontinued operations attributable to common shareholders | 21 | (54) | 31 | (256) |
| Net income (loss) attributable to common shareholders | $2,028 | $1,266 | $4,006 | $2,805 |
(a) Other segment expenses (income) primarily includes equity method income, interest income and licensing and royalty income.
342025 2Q FORM 10-Q
REMAINING PERFORMANCE OBLIGATION. As of June 30, 2025, the aggregate amount of the contracted revenue allocated to our unsatisfied (or partially unsatisfied) performance obligations was $174,397 million. We expect to recognize revenue as we satisfy our remaining performance obligations as follows: (1) equipment-related remaining performance obligation of $24,389 million, of which 37%,63% and 92% is expected to be satisfied within 1,2 and 5 years, respectively; and (2) services-related remaining performance obligation of $150,008 million, of which 13%,43%,70% and 87% is expected to be recognized within 1,5,10 and 15 years, respectively, and the remaining thereafter.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.